Navigation Links
Horizon Technology Finance Closes $2 Million Venture Loan Facility with New Haven Pharmaceuticals
Date:4/25/2013

FARMINGTON, Conn. and GUILFORD, Conn., April 25, 2013 /PRNewswire/ -- Horizon Technology Finance Corporation (Nasdaq: HRZN) ("Horizon"), a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and clean-tech industries, today announced it has closed a $2 million venture loan facility with New Haven Pharmaceuticals, Inc. ("NHP"), a developer of prescription pharmaceuticals that utilize currently marketed drugs or active pharmaceutical ingredients generally recognized as safe for use in therapeutic applications. The proceeds of the venture loan facility will be used for working capital purposes.

"We are pleased to provide NHP with a venture loan facility which will support its development of proprietary prescription pharmaceuticals," stated Gerald A. Michaud , President of Horizon. "NHP continues to achieve important strides in developing products for patients with a higher risk for secondary strokes or acute cardiac events. Based on the company's impressive product pipeline and experienced, well-respected management team, NHP represents a strong addition to Horizon's high-quality investment portfolio."

"Horizon's $2 million venture loan facility provides NHP with the right capital structure and the timely liquidity to continue to execute our product development and FDA registration plans," stated Patrick P. Fourteau, NHP's President & CEO. Harry H. Penner, Jr. , NHP's Executive Chairman, added, "The responsiveness and flexibility of the Horizon team resulted in a seamless process from initial contact to funding and a very positive business experience. It's gratifying to have Horizon, a Conn
'/>"/>

SOURCE Horizon Technology Finance Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Future Horizons in the Global Orthopedics Market
2. Horizon Pharma Announces Issuance of U.S. Patent Covering RAYOS (delayed-release prednisone)
3. 110+ Health Care Providers Announce Plans To Use Advanced Medical Records Technology To Improve Care For Thousands Of Denver-Area Patients
4. Memorial Hospital of Lafayette County Boosts Patient Safety with Expanded Use of Capnography Technology
5. TriMix Laboratories Announces New TriMix-gel Partnership with KRS Global Biotechnology
6. Endexx to attend NAMA Spring Expo for Medical Marijuana Technology Solutions
7. Creabilis Awarded Prestigious European Commission FP7 Grant to Further Develop its LSE Topical-by-Design Technology
8. iBio Passes Commercial Technology Transfer Milestone
9. Sanovas Launches Next Generation Surgical Imaging Technology
10. George Rosenkranz to Receive 2013 Biotechnology Heritage Award
11. Besins Healthcare, Shin Nippon Biomedical Laboratories, Ltd Announce Delivery Technology Licensing Agreement for Intranasal Progesterone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Decision Resources Group ... the EU5 countries ( France , ... Spain and the ... of the first once-daily long-acting beta2 agonist/inhaled corticosteroid (LABA/ICS) ... uptake of Relvar as a first-line LABA/ICS FDC in ...
(Date:7/24/2014)... DALLAS , July 24, 2014 /PRNewswire-iReach/ -- ... days once order is placed. Photo ... is a professional and in-depth market survey on ... firstly reviews the basic information of Hemodialysis Machine ... report then explores global and China,s top manufacturers ...
(Date:7/24/2014)... , July 24, 2014   Royal Philips ... announced that it has received 510(k) clearance from the ... ultra mobile ultrasound system, VISIQ, in the U.S. ... combine the benefits of greater mobility, performance and simplicity ... to quality diagnostic scans for more OB patients. ...
Breaking Medicine Technology:Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 2Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 3
... N.C., Feb. 28, 2011 Goodrich Corporation (NYSE: ... advanced helicopter technology that brings real-time information to air ... enhanced safety and rescue systems. Heli-Expo 2011 takes place ... in Orlando, Fla.   Goodrich (booth 2142) ...
... PHILADELPHIA, Feb. 28, 2011 Shire plc , (LSE: ... company, today announced that the US Food and Drug Administration ... Tablets as adjunctive therapy to stimulants for the treatment ... ages 6 to 17 as part of a total treatment ...
Cached Medicine Technology:Goodrich to Showcase Advanced Helicopter Systems at Heli-Expo 2FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 2FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 3FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 4FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 5FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 6
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 Just ... seriously, they must consider their own financial and marketing ... and weak marketing campaigns to the next level by ... Cloud Call Center, IVR, Voice Broadcast, Call Tracking and ... a 98% open rate, text messages are quickly become ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, 2014 (HealthDay News) -- ... according to a small study that asked boys what they really ... the ages of 14 and 16, researchers found that most said ... trust. Very few boasted about sexual conquests or saw sex as ... "In our culture, we have lots of assumptions about how guys ...
(Date:7/24/2014)... July 24, 2014 CarePoint Health ... in hematology and oncology, Dr. Hitendra Upadhyaya, has ... system welcomes Dr. Upadhyaya to the community. Hundreds ... Health Medical Group, a comprehensive network of top ... wide range of specialties. This latest acquisition represents ...
(Date:7/24/2014)... to increase the risk for head and neck cancer (HNC). ... DM, but the risk of HNC in patients with DM ... is the sixth most common type of cancer. It accounts ... estimated 650,000 new cancer cases and 350,000 cancer deaths worldwide ... Research Database to examine the risk of HNC in patients ...
(Date:7/24/2014)... found a way to delay or even prevent Alzheimer,s ... the anti-aging protein Klotho can prevent neuron death in ... These findings currently appear in the Journal of ... most frequent age-related dementia affecting 5.4 million Americans including ... more than 40 percent of people over the age ...
Breaking Medicine News(10 mins):Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3Health News:Dr. Upadhyaya Joins CarePoint Health Medical Group 2Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2
... commonly used by spies instead of scientists with the ... a Penn neurologist has developed a new approach for ... pattern is encoded in the seemingly random order of ... reveals when observed with fMRI. The research is published ...
... All medications have side-effects from common aspirin to ... experimental immunosuppressants. However, predicting important side effects, serious ... almost impossible. However, a neural network technology trained ... healthcare workers a new tool to spot the ...
... March 28 (HealthDay News) -- Teenagers who begin smoking at ... marijuana by the time they,re 17, researchers report. Their ... began in 1994 found that by the time they were ... boys had used marijuana or other illicit substances at least ...
... research documenting changes in the incidence and outcomes of ... and 2006, found a significant increase in incidence rates ... in African Americans. A second related studythe largest pediatric ... adverse outcomes among children with ESRD due to lupus ...
... activity of hundreds of individual human brain cells during ... neuronal activity, contrary to the classic view that they ... by Massachusetts General Hospital (MGH) and Brown University researchers ... the cells where seizures originate and in nearby cells. ...
... , SUNDAY, March 27 (HealthDay News) -- Baseball pitchers intentionally ... new study. Researchers analyzed data from more than 57,000 ... that pitchers whose teammates were hit by a pitch were ... reached 90 degrees F than on cooler days. If ...
Cached Medicine News:Health News:Deciphering hidden code reveals brain activity 2Health News:Predicting serious drug side effects before they occur 2Health News:Study finds changes in incidence of end-stage renal disease from lupus nephritis 2Health News:Study finds changes in incidence of end-stage renal disease from lupus nephritis 3Health News:Advanced technology reveals activity of single neurons during seizures 2
Pronto Dry is intended for use for the detection of urease enzyme in gastric mucosal biopsy specimens....
Serim PyloriTek Test Kit detects urease activity in gastric biopsy specimens for the presumptive identification of an Helicobacter pylori infection....
... Rapid Test Strip and Device are rapid ... antibodies to Helicobacter pylori (H. pylori) in ... in the diagnosis of H. pylori infection ... older. They are intended for health professionals ...
... The QuickVue H.pylori gII test is ... rapid, qualitative detection of IgG antibodies specific ... or whole blood. It utilizes a convenient, ... to aid physicians in the diagnosis of ...
Medicine Products: